Studies on polynuclear furoquinones. Part 1: Synthesis of tri- and tetra-cyclic furoquinones simulating BCD/ABCD ring system of furoquinone diterpenoids by Faruk H. Shaik & Gandhi K. Kar
Page 1 of
(page number not for citation purposes)
7
Studies on polynuclear furoquinones. Part 1:
Synthesis of tri- and tetra-cyclic furoquinones
simulating BCD/ABCD ring system
of furoquinone diterpenoids
Faruk H. Shaik and Gandhi K. Kar*
Full Research Paper Open Access
Address:
Department of Chemistry, Presidency College, 86/1 College Street,
Kolkata-700073, India, Tel: +9133 2241-3893
Email:
Faruk H. Shaik - fhs_chem@yahoo.co.in; Gandhi K. Kar* -
gandhikar41@hotmail.com
* Corresponding author
Keywords:
Fremy’s salt oxidation; furonaphthoquinone; furophenanthraquinone;
Suzuki reaction
Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
doi:10.3762/bjoc.5.47
Received: 13 June 2009
Accepted: 20 August 2009
Published: 29 September 2009
Associate Editor: J. Aubé
© 2009 Shaik and Kar; licensee Beilstein-Institut.
License and terms: see end of document.
Abstract
Synthesis of phenanthro[1,2-b]furan-10,11-dione, the core nucleus present in Tanshinone-I is described in 8–10 steps starting from
2-bromo-3,4-dihydro-1-naphthaldehyde. The bromoaldehyde was converted to methyl 2-(2-bromo-1-naphthyl)acetate or 2-(2-
bromo-1-naphthyl)acetonitrile following the protocol of functional group transformations. Subsequent Suzuki coupling of this ester/
nitrile derivative with furan-2-boronic acid produced [2-(2-furyl)-1-naphthyl]acetic ester/nitrile which on hydrolysis furnished the
corresponding acid derivative. Cyclization of the acid followed by oxidation of the phenol, with Fremy’s salt, produced the tetra-
cyclic furoquinone, phenanthro[1,2-b]furan-10,11-dione. This method has also been extended for the synthesis of the tricyclic
furoquinone, naphtho[1,2-b]furan-4,5-dione.
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Introduction
Chemistry of furoquinones [1-8], especially the tetra cyclic
furoquinones isolated from Chinese red rooted sage Salvia
miltiorrhiza Bunge known as “Dan Shen” in Chinese tradi-
tional medicine, attracted the attention of synthetic chemists as
well as medicinal chemists due to the various biological activ-
ities displayed by such class of compounds. Dan Shen is used
clinically for treatment of viral hepatitis, cardiac and vascular
disorder, hypertension, miscarriage and menstrual disorder [3,9]
etc. It has been reported to show potential anticancer activity
[10] (against human breast cancer), cytotoxic and antiplatelet
aggregation activities [1,11]. It also acts as an antibacterial [1],
antioxidant and anti-inflammatory agent [12-14] as well as
induces apoptosis in human leukemia cell lines [15,16]. It is
believed that broad spectrum of activities of Dan Shen are
mainly associated with the presence of tetra cyclic furoquinone
diterpenoids like Tanshinone I [17,18], Tanshinone IIA and IIB
[19-26], Cryptotanshinone [20,22], Nortanshinone [23,27],
Tanshindiol [23,27] etc. (Figure 1). Even the tricyclic
furoquinones (Figure 1) have also been reported to possess
cancer chemo preventive activity [28].Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
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Figure 1: Some biologically active tetra cyclic furoquinone derivatives (isolated from Dan Shen) and synthetic tricyclic furoquinones.
Figure 3: Retro synthesis of tetra cyclic furoquinone 13.
In all of these compounds the key structural unit present is a
furophenanthraquinone or a furonaphthoquinone as well as their
di/tetra/hexahydro analog.
We have not come across any synthesis of phenanthro[1,2-
b]furo-10,11-dione (13) (the nuclear core structure of
Tanshinone-I) though a number of syntheses of naturally occur-
ring tetra cyclic furoquinone diterpenoids have been reported in
literature [18-27] in the last few decades. In comparison only
very few syntheses of tricyclic furoquinone 18 [29,30] and its
derivatives [31-33] have been reported. Encouraged by the
broad spectrum biological activity of furoquinones, we aimed to
synthesize novel polynuclear furoquinones. Herein we report
the synthesis of tetra cyclic furoquinones, phenanthro[1,2-
b]furan-10,11-dione (13) and the tricyclic furoquinone,
naphtho[1,2-b]furan-4,5-dione (18), simulating respectively the
A-B-C-D/B-C-D ring of Tanshinone-I, through a novel
pathway.
Results and Discussion
Our aim is to develop a general route for the synthesis of
tricyclic/tetracyclic furoquinones with structural diversity. Our
approach is shown in Scheme 1 and Scheme 2. In the synthesis
of the tetra cyclic furoquinone 13, an easily available starting
material 2-bromo-3,4-dihydro-1-naphthaldehyde 1 [34] was
utilized as A, B ring precursor and commercially available furan
2-boronic acid as D-ring precursor. In the event of the synthesis,
the C ring was constructed to reach the target molecule in 8-10
steps. The key steps in our synthesis deal with the formation of
aryl-furyl C–C bond via Suzuki reaction [35] and the genera-
tion of the quinone functionality by oxidation of a phenolic
intermediate (Figure 2).
Figure 2: Key strategies for development of C-ring with quinone func-
tionality.
Retrosynthesis of the molecule showed that the required phen-
olic compound can easily be achieved in 7–8 steps starting from
2-bromo-3,4-dihydro-1-naphthaldehyde (a substrate easily
available by Vilsmeier–Haack reaction on 2-tetralone) and
furan-2-boronic acid (a commercially available material)
(Figure 3).Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
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Scheme 1: Reagents and conditions: i) DDQ (1.5 equiv), dry benzene, reflux, argon atmosphere, 37 h, 83%. ii) NaBH4, EtOH, room temperature, 2 h,
94%. iii) PBr3, CCl4, 60 °C, 1 h, 82%. iv) KCN, DMF, room temperature, overnight then 1 h at 50 °C, 68%. v) KOH, EtOH, H2O, reflux, 23 h, 74%. vi)
CH2N2, ether, 0 °C- room temperature, 95%. vii) furan-2-boronic acid (1.2 equiv.), Et3N, DMF, Pd(PPh3)4 (2 mol %), 110 °C, argon atmosphere, 53 h, 77%. viii) KOH (2 equiv), EtOH, H2O, reflux, 15 h, 85%. ix) furan-2-boronic acid (1.2 equiv), Et3N, DMF, Pd(PPh3)4 (2 mol %), 110 °C, argon atmo- sphere, 37 h, 66%. x) KOH, EtOH, H2O, reflux, 45 h, 48%. xi) TFAA, TFA, room temperature, overnight, 71%, xii) Fremy’s salt (3 equiv), MeOH, 1/6 M
Na2HPO4 solution. 0–5 °C, overnight, 48%. (All yields are for purified products only.)
Scheme 2: Reagents and conditions: i) furan-2-boronic acid (1.2 equiv), Et3N, DMF, Pd(PPh3)4 (2 mol %), 110 °C, N2 atmosphere, 7 h, 84%, ii) KOH, EtOH, H2O, reflux, 9 h, 90% iii) TFAA, TFA, room temperature, overnight, 54%, iv) Fremy’s salt (~2.5 equiv), MeOH, 1/6 M Na2HPO4 solution, 0–5 °C,
overnight, 56%. (All yields are for purified products only.)
When 2-bromo-3,4-dihydro-1-naphthaldehyde (easily obtained
in 68% yield by the reaction of 2-tetralone and PBr3/DMF in
CHCl3 at room temperature) was aromatized with DDQ in
refluxing benzene, 2-bromo-1-naphthaldehyde (2) was
produced in excellent yield. Reduction (NaBH4/EtOH) of the
aldehyde 2 produced the alcohol 3 as a colorless solid, in 94%
yield, which on reaction with PBr3/CCl4 produced the bromide
4 as a light yellow solid. The bromide was then converted
(KCN/DMF) to the nitrile derivative 5 which on hydrolysis
(KOH/EtOH-H2O, reflux) followed by esterification with
CH2N2 furnished methyl 2-(2-bromo-1-naphthyl)acetate 7 in
overall good yield. The bromo ester was then subjected to
Suzuki reaction with furan-2-boronic acid.
Reaction of compound 7 with furan-2-boronic acid in the pres-
ence of Et3N and Pd(PPh3)4 (cat.) in DMF under argon atmo-Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
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Figure 4: Assignment of chemical shifts (1H NMR and 13C NMR) of compound 13.
sphere produced methyl [2-(2-furyl)-1-naphthyl]acetate 8 (77%)
which  when  hydrolyzed  furnished  [2-(2-furyl)-1-
naphthyl]acetic acid (9) in 85% yield. The acid 9 was also
synthesized via hydrolysis of the nitrile derivative 10 which in
turn was obtained in 66% yield, by direct Suzuki reaction of 5
with furan-2-boronic acid. However in this case as the interme-
diate amide 11 produced was resistant to further hydrolysis, the
reaction required prolonged reflux and also the yield was relat-
ively poor. Even after reflux of the nitrile derivative 10 in KOH/
EtOH-H2O for 45 h 20% of the amide 11 was recovered along
with 48% of the desired carboxylic acid. Change of solvent and
conditions (e.g., replacement of ethanol with other high boiling
alcohols or use of THF as co-solvent and higher temperature)
produced no better result. The next step was the introduction of
the phenol functionality. In this case our early attempt to
prepare the phenol 12 by PPA cyclization of the acid 9 was
unsuccessful. We however successfully prepared the phenol as
a light yellow solid by cyclization of the acid 9 with trifluoro-
acetic acid (TFA) and trifluoroacetic anhydride (TFAA) at room
temperature in 71% yield. The phenol 12 was finally oxidized
(with Fremy’s salt) [36-38] to the o-quinone 13 to complete the
synthesis of phenanthro[1,2-b]furan-10,11-dione. The
compounds were characterized by usual spectroscopic and
analytical methods (1H NMR, 13C NMR, IR, HRMS etc.).
The developed pathway was then applied for the synthesis of
tricyclic furoquinone 18 (naphtho[1,2-b]furan-4,5-dione)
starting from methyl (2-bromophenyl)acetate 14 and furan-2-
boronic acid (Scheme 2).
When methyl (2-bromophenyl)acetate 14 was subjected to
Suzuki reaction with furan-2-boronic acid, produced [2-(2-
furyl)phenyl]acetic ester 15 as a pale yellow liquid in 84%
yield. Subsequent alkaline hydrolysis of 15 produced the
carboxylic acid 16 as a white solid in 90% yield. Synthesis of
the furonaphthol 17 was achieved in good yield, by cyclization
of the carboxylic acid 16 with TFA and TFAA at room temper-
ature. Finally oxidation of the naphthol derivative 17, with
Fremy’s Salt, resulted in the formation of naphtho[1,2-b]furan-
4,5-dione (18), as a red solid, in 56% yield. The compounds
have been characterized by usual spectroscopic analysis (NMR,
IR and HRMS data) as well as by analogy with literature report
[30].
In general we have developed a novel pathway for the synthesis
of polynuclear furoquinones simulating BCD/ABCD ring of
natural furoquinone (Tanshinone-I) and we believe the method
has great potential towards the synthesis of various polynuclear
furoquinone derivatives bearing electron donating/electron
withdrawing functionality within its framework as bromoalde-
hyde derivatives bearing such groups can easily be obtained
from corresponding ketones by Vilsmeier–Haack reaction. Very
recently we have reported a general method for the synthesis of
β-(2-furyl)-α,β-unsaturated aldehydes [39] via Suzuki reaction
of β-bromo-α,β-unsaturated aldehydes. These substrates can be
used for the synthesis of various non-natural tricyclic and
“U-shaped” tetra cyclic furoquinone derivatives. The work is
under progress and the results will be published in due course.
Experimental
Furan-2-boronic acid, 2-tetralone and tetrakis(triphenylphos-
phine)palladium(0) and DDQ were purchased from Sigma-
Aldrich (U.S.A). Trifluoroacetic anhydride was purchased from
Alfa Aesar (Lancaster). 2-Bromo-3,4-dihydronaphthalene-1-
carbaldehyde was prepared from 2-tetralone by Vilsmeier-
Haack reaction. Solvents were dried following standard liter-
ature procedure. Fremy’s salt (potassium nitrosodisulfonate)
was prepared in the laboratory as per literature procedure [36].Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
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1H NMR spectra were recorded on Bruker 500 MHz (at
Chemgen Pharma, Kolkata) and Bruker 400 MHz (at Chembi-
otek International, Kolkata) and Bruker 300 MHz (IACS,
Kolkata) NMR spectrometer respectively. ESI mass spectra
were recorded on a micro mass Q-TOF mass spectrometer
(serial no. YA 263) at IACS, Kolkata. IR spectral data were
obtained from a JASCO FT/IR680 PLUS Spectrometer.
[2-(Furan-2-yl)-naphthalen-1-yl]acetic acid
methyl ester (8)
A mixture of compound 7 (150 mg, 0.54 mmol), furan-2-
boronic acid (75 mg, 0.64 mmol) and Et3N (0.5 mL, 3.6 mmol)
was degasified with argon for 25 minutes. Now to it the cata-
lyst Pd(PPh3)4 (~15 mg, 2 mol %) was added. The mixture was
then heated with stirring under argon at 110 °C till the reaction
was completed (~53 h). After cooling to room temperature, the
mixture was poured into cold water and extracted with ether.
Organic layer was washed successively with NaHCO3 solution,
5% brine and dried (Na2SO4) and solvent removed. Crude
product thus obtained was then purified by column chromato-
graphy [silica gel/ pet. ether (60–80 °C) and ethyl acetate
mixture, 10:1]. Compound 8 was obtained as a white solid (110
mg) in 77% yield, m.p., 109–111 °C. IR(KBr) νmax : 1737.6
cm−1; 1H NMR (400 MHz, CDCl3) δ: 3.72 (3H, s), 4.33 (2H, s),
6.53 (1H, dd, J = 1.7 and 3 Hz), 6.67 (1H, d, J = 3 Hz), 7.50
(1H, t, J = 7.2 Hz), 7.56 (1H, d, J = 7.2 Hz), 7.57 (1H, br s),
7.72 (1H, d, J = 8.6 Hz), 7.82 (1H, d, J = 9.4 Hz), 7.84 (1H, d, J
= 9.3 Hz), 8.01 (1H, d, J = 8.4 Hz), ppm.
[2-(Furan-2-yl)-naphthalen-1-yl]acetic acid (9)
A mixture of compound 8 (100 mg, 0.38 mmol), KOH (43 mg,
0.76 mmol), 2 mL water and 2 mL ethanol was refluxed on a
water bath for 15 h. Excess EtOH was distilled out as much as
possible and then the residue was diluted with 2–3 mL of water.
Neutral part was extracted with ether. Aqueous alkaline part
was cooled in ice and acidified with HCl. Separated solid was
thoroughly extracted with ethyl acetate. After usual work up, 80
mg (85%) of the acid 9 was obtained as white solid, m.p.,
197–199 °C. IR (KBr) νmax 1692.2 cm−1. (Treatment of the acid
9 with diazomethane in ether produced the methyl ester deriv-
ative identical with compound 8.)
Phenanthro[1,2-b]furan-11-ol (12)
A mixture of compound 9 (100 mg, 0.39 mmol), 3 mL trifluoro-
acetic anhydride, 0.9 mL trifluoroacetic acid was stirred at room
temperature overnight protecting from moisture. The mixture
was then poured in ice cold saturated NaHCO3 solution and
stirred well and extracted thoroughly with CH2Cl2. The organic
layer was washed with aq. NaHCO3 solution and finally with
H2O and dried (Na2SO4). Removal of solvent afforded the
crude product which was purified by column chromatography
[silica gel/pet. ether (60–80 °C) and ethyl acetate mixture, 19:1]
to furnish 65 mg (71%) of 12 as a light yellow solid, m.p.,
175–177 °C. IR (KBr) νmax 3235, 3302 cm−1; 1H NMR (500
MHz, CDCl3) δ: 5.47 (1H, s), 7.04 (1H, br s), 7.58 (1H, t, J =
7.4 Hz), 7.63 (1H, t, J = 7.5 Hz), 7.75 (1H, d, J = 8.8 Hz), 7.78
(1H, br s), 7.85 (1H, s), 7.91 (1H, d, J = 7.8 Hz), 8.22 (1H, d, J
= 8.8 Hz), 8.55 (1H, d, J = 8.2 Hz) ppm.
Phenanthro[1,2-b]furan-10,11-dione (13)
To a stirred solution of potassium nitrosodisulfonate (Fremy’s
salt) (170 mg, 0.65 mmol) in 12 mL 1/6 (M) Na2HPO4 solution
taken in a 50 mL round bottomed flask, a solution of the
furonaphthol derivative 12 (50 mg, 0.21 mmol) in 6 mL meth-
anol was added drop wise. Stirring was continued at 0–5 °C for
2 h and then left overnight in freeze. The dark red solid separ-
ated was filtered and purified by column chromatography [silica
gel/ pet. ether (60–80 °C) and ethyl acetate, 10:1]. An analyt-
ical sample was prepared further by recrystallisation from pet
ether–ethyl acetate mixture. Yield, 25 mg (48%), m.p.,
178–180 °C. IR (KBr) νmax 1686, 1667 cm−1; 1H NMR (500
MHz, CDCl3) δ: 6.87 (1H, br s), 7.53 (1H, d, J = 7.5 Hz), 7.55
(1H, br s), 7.70 (1H, br t, J = 7.5 Hz), 7.81–7.85 (2H, a doublet
and a triplet merged together), 8.12 (1H, d, J = 8.5 Hz), 9.40
(1H, d, J = 8.5 Hz) ppm; 13C NMR (125 MHz, CDCl3) δ:
109.11, 119.16, 120.79, 122.88, 126.66, 127.66, 129.20, 130.07,
131.20, 132.47, 134.65, 137.33, 145.54, 161.31, 174.53, 183.07
ppm; HRMS (ESI, 70 eV): m/z = 271.0372 [M++Na] (calcu-
lated mass for C16H8O3Na: 271.0371 [M++Na]).
Naphtho[1,2-b]furan-4,5-dione (18)
To a stirred solution of potassium nitrosodisulfonate (Fremy’s
salt) (170 mg, 0.63 mmol) in 5 mL 1/6 (M) Na2HPO4 solution
taken in a 25 mL round bottomed flask, a solution of the
furonaphthol 17 (50 mg, 0.27 mmol) in 2 mL methanol was
added drop wise. Stirring was continued at 0–5 °C for 2 h and
then left overnight in freeze. The brick red solid separated was
filtered to obtain 35 mg of crude product which on purification
by column chromatography (silica gel/pet. ether–ethyl acetate,
5:1) afforded 30 mg (56%) of the title compound (18). An
analytical sample was prepared by further recrystallisation from
pet. ether–EtOAc mixture; m.p., 205–206 °C (lit. [30] m.p
213–215 °C ). IR(KBr) νmax 1674.9 cm−1 (br, strong); 1H NMR
(500 MHz, CDCl3) δ: 6.88 (1H, d, J = 1.8 Hz), 7.48 (1H, t, J =
7.5 Hz), 7.51 (1H, d, J = 1.8 Hz), 7.67 (1H, t, J = 7.5 Hz), 7.74
(1H, d, J = 7.5 Hz), 8.1 (1H, d, J = 7.7 Hz) ppm; 13C NMR (125
MHz, CDCl3) δ: 108.94, 121.56, 122.41, 128.49, 128.81,
130.36, 130.64, 135.48, 145.13, 160.64, 174.54, 180.56 ppm.
HRMS (ESI, 70 eV): m/z = 199.0399 [M++H] (calculated mass
for C12H7O3: 199.0391 [M++H]).[lit. [30]: 1H NMR (300 MHz,
CDCl3) δ: 8.09 (1H, d, J = 7.9 Hz), 7.73–7.62 (2H, m), 7.49
(1H, d, J = 2.0 Hz), 7.45 (1H, m), 6.86 (1H, d, J = 2.0 Hz)].Beilstein Journal of Organic Chemistry 2009, 5, No. 47.
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Supporting Information
Supporting information features experimental procedures,
analytical data and NMR spectra for some selected
compounds.
Supporting Information File 1
Experimental procedures
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-5-47-S1.doc]
Supporting Information File 2
1H and 13C NMR Spectra.
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